GoHealth, Inc. (NASDAQ:GOCO) Q2 2023 Earnings Call Transcript August 10, 2023
GoHealth, Inc. misses on earnings expectations. Reported EPS is $-3.27 EPS, expectations were $2.66.
Operator: Good day and thank you for standing by. Welcome to the GoHealth Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised today’s conference is being recorded. I would now like to hand the conference over to your speaker today, John Shave, Vice President of Investor Relations. Please go ahead.
John Shave: Thank you, and good morning, everyone. Thanks for joining GoHealth’s second quarter 2023 earnings call. Joining me today are Vijay Kotte, Chief Executive Officer; and Jason Schulz, Chief Financial Officer. Today’s conference call contains forward-looking statements based on our current expectations. Numerous risks and uncertainties may cause actual results to differ materially from those anticipated or projected in these statements. Many of the factors that will determine future results are beyond the company’s ability to control or predict. You should not place undue reliance on any forward-looking statements. And the company undertakes no obligation to update or revise any of these statements, whether due to new information, future events or otherwise.
Earlier today, we issued a press release containing our results for the second quarter of 2023. We have posted the release on the GoHealth website under the Investor Relations tab. In the press release, we’ve listed a number of risk factors, which you should consider in conjunction with our forward-looking statements. We encourage you to consider the other Risk Factors described in our Form 10-K and Form 10-Q reports filed with the Securities and Exchange Commission for additional information. During this call, we will be discussing certain non-GAAP financial measures. These measures are reconciled to the most directly comparable GAAP financial measures, and the reconciliations are set forth in the press release. Please refer to the Investor Relations section of our website for reconciliations of non-GAAP measures to the most comparable GAAP measures discussed this earnings call.
I’ll now turn the call over to GoHealth’s CEO, Vijay Kotte.
Vijay Kotte: Thank you, John. Good morning and thank you all for joining us today. I’m pleased to report another strong quarter. Together with our external partners, we helped over 162,000 Medicare consumers assess their coverage, review potential Medicare options, and enroll in a plan. Our marketplace model is distinct from traditional brokers in several ways. At GoHealth, we remain unbiased and put the consumer at the center of all we do. We achieved $140 million in revenue, nearly $1 million in adjusted EBITDA, and almost $11 million in positive cash flow. We continue to see improved profitability as we accomplished a significant milestone by reaching positive adjusted EBITDA in Q2 compared to a loss of just under $32 million in second quarter of 2022, which is particularly noteworthy given the historical dynamics of losses in the quarter due to carrying costs versus volume.
This accomplishment is a testament to the intentional resizing decisions we made last year, which had a positive impact on our exit runway. Additionally, our strategic deployment of automation and technology played a pivotal role in driving operational efficiencies, while turning the corner to prudent growth going forward on a year-over-year basis. Our growth and exceptional results have exceeded expectations providing us with the competence to elevate our financial guidance for the remainder of the year. With this impressive performance, we now expect 2023 total net revenue of between $800 million and $850 million, an increase from the previous lower bound of $750 million. Furthermore, our projected adjusted EBITDA range is set to reach between $120 million and $140 million surpassing the previously lower bound of $100 million.
Please recall there our guidance excludes non-Encompass BPO services. I want to highlight that with our strategic exit of non-Encompass BPO services, we believe we have transitioned to a phase of profitable growth accompanied by improving cash flow generation. You can see this in our second quarter results as compared to last year, and we expect this to continue for the rest of 2023, as also evidence in our revised guidance. We are driving efficiencies in the best way possible by doing more with the same, and this applies to our seasoned agents, streamlined onboarding process, standardized Encompass model, and proprietary technology, all of which we expect to continue to improve and enhance. As we said in Q4 2022, Medicare plan shopping will increase.
It has increased as both peers and partners have recently confirmed. We believe beneficiaries now switch plans as many as 3x to 5x over the course of their eligibility as their needs change. So they should shop at least once a year. We anticipated last year that consumer shopping would continue and may impact churn. The increase in consumer shopping was a driver of the change in estimate we did at the end of 2022, and we took that into account for our 2023 guidance. If consumers are going to shop, we want them to shop with us regardless of whether we originally enrolled them in their plan. More consumers will shop with us if we build a trusted relationship by delivering an unbiased, high quality, consumer shopping experience. This approach leverages an agnostic consumer marketplace with multiple plan options and develops credibility with consumers.
We want to be the destination that provides consumers with a needs based checkup every year, where the results might mean the consumer stays in their current plan if it is the best plan for their needs. If it’s not the best plan, we make it easy to enroll in the better one. We remain committed to enhancing the personalization of the consumer experience, which has been a driving force behind our Encompass transformation. As we have said in the past, we expect plan shopping to continue to increase, and our long game is to invest in relationships and align incentives. We are providing a trustworthy shopping experience that allows consumers to select a Medicare plan that meets their unique needs. With the GoHealth shopping experience built on the Encompass operating model, we offer a personalized, unbiased, and no pressure shopping experience where consumers can feel comfortable and confident throughout the entire process focused on shopping and not selling.
![Surgery, Medicine, Health](https://imonkey-blog.imgix.net/blog/wp-content/uploads/2022/12/30165526/national-cancer-institute-L8tWZT4CcVQ-unsplash-1.jpg?auto=fortmat&fit=clip&expires=1755993600&width=480&height=320)
Photo by National Cancer Institute on Unsplash
Most of the time, shopping does not result in an enrollment especially we find that consumer is already on the best plan, but we believe it should always result in a discussion on the best option for them. We have recently implemented the Plan Fit checkup where we are compensating our agents for their time spent with consumers, even if they assess that the current plan remains the strongest fit for them in their service area and no switching is needed at that time. We view the Plan Fit checkup as an investment in a long-term relationship with consumer and believe the shopping process enhances trust even if the interaction with the consumer doesn’t result in a new enrollment today. We developed a Plan Fit checkup throughout Q2 and recently launched it in Q3.
Preliminary results show improved agent and consumer sentiment with limited operational impacts indicating more robust consumer and agent experience. Our agents are excited about the Plan Fit checkup, and we believe it could help us become the broker of choice for agents. This investment is contemplated in our guidance and plan. As we discussed last quarter, we continue to enhance our technology to drive overall efficiency in our model and improve the consumer experience. Our Plan Fit tool is built-on millions of consumer interactions and leverages that data to create a customized, guided, multi-step shopping experience. The tool continues to evolve as we write more policies, gather more data and add model features. Our testing continues to build momentum with the last AEP showing plans ranked number one by Plan Fit where both the most selected for consumers and had 10% higher 90-day retention.
Our unified agent experience has streamlined and enhanced the process for agents to assist consumers resulting in a faster agent onboarding, as well as improved compliance and efficiency. Onboarding for new agents has been reduced by 33%. In Q2, we successfully launched a new guided experience to all agents delivering approximately 5% improvement in quality scores and path to competency for new agents. We are excited about the possibilities that lie ahead and look forward to redefining excellence in consumer experience. Finally, I’m delighted to share the significant strides we’re making with the operationalization and implementation of Customer 360, a transformative data initiative that drives improvement now and serves as a foundation for GoHealth’s future.
In the near-term, Customer 360 drives better call routing, better organization of consumer data, and improved ability to recall consumer data. Based on our proprietary matching algorithms, we can clearly measure that just over 20% of our inbound calls are coming from previous shoppers who may or may not have enrolled through us, but can now have a more streamlined, consistent experience only verifying information as opposed to starting from scratch. In the future, we expect Customer 360 will revolutionize the way we interact with consumers and consider each consumer’s historical relationship with GoHealth. This will drive meaningful, improved efficiency for our agents and prepare us to succeed in the future where consumers are empowered to enroll in and manage their Medicare Advantage on their own terms, whether telephonically, digitally, or some combination of the two.
Our belief in the Encompass model’s value for health plans is backfire ability to redefine and reset the foundation of our business through our new contracts. We have entered multi-year Encompass contracts with nearly all our major health plan partners, making it clear that Encompass and the verified enrollment and plan onboarding processes that we have developed will position us to deliver a world class consumer experience. Alongside these multi-year contracts with our health plan partners, we believe our incentives are set up in a way that will allow us to best support consumers to shop for the best plan available as their needs change on a yearly basis, and incent health plan partners to continue to invest in competitive products to win and retain consumers.
As we have introduced and rolled out our guided shopping process at scale across our Tier 2 agents, we have been able to expand the number of health plans we offer to our consumers, ensuring that the most competitive product in the region is available to them. We are focused on active rates as the members we place in health plans, ensuring that we will deliver higher effectuation at 90-day active rates for our health plan partners. We also realized that consumer needs will not stay static over time, and we owe it to our consumers to help them assess their options as new plans become available in their area and decide whether to try something new or stay where there are. Our redefined Encompass solution has driven higher quality enrollments, resulting in fewer CTMs, higher fluctuation rates, and greater member retention.
As always, AEP preparation is a key focus for us. We are on track with our staffing and training plan along with our operational and product focused work slated to be released prior to AEP resulting in a more efficient agent experience. We continue to collaborate with our health plan partners and remain confident that we will successfully be able to navigate the CMS final rule changes inclusive of the 48-hour rule and are supportive of CMS’ position to strengthen the consumer experience. The efficiency we are driving with our Encompass model is flowing through our financials with lower cash burns and lower costs, delivering economies of scale and revenue reliability while reinforcing consistent and high quality consumer experience. With that, I’d like to thank our team and partners for the loyalty and dedication during this transformative time.
And I’ll now turn it over to Jason to detail the financials and our updated guide.
Jason Schulz: Thanks, Vijay. I’m pleased to present our Q2 2023 financial results. Our Q2 performance has exceeded expectations with margin expansion and improved operational efficiency leading to a strong quarter. Second quarter revenue after adjusting for the exit of our non-Encompass BPO services was $140.3 million demonstrating growth compared to the $138.7 million generated in the second quarter of last year. While our year-over-year growth is modest, we are pleased to be turning the corner for long-term sustained top and bottom line financial growth. Our strong Q2 revenue performance was driven by over 162,000 submissions representing a increase of 5% year-over-year. Our second quarter adjusted EBITDA of $800,000 marks like $33 million improvement compared to the same period of last year.
The year-over-year increase is largely driven by the continued benefits from the Encompass operating model, which has created significant efficiency gains. These improvements are a testament to our continued commitment for sustained growth and profitability. In Q2, we recorded $11 million for legal exposure related to our securities litigation. This accrual is not indicative of any procedural developments in the litigation and will remain confident in our defenses. In the second quarter of 2023, we achieved $11 million of positive cash flow from operations, a significant turnaround from the negative cash flow of $48 million in the prior year period. As illustrated in our quarterly results presentation posted on our website, our trailing 12-month cash flow from operations as of Q2 2023 is $86 million.
This accomplishment represents a $346 million improvement compared to the same trailing 12-month period last year. While $107 million of this improvement can be attributed to the non-agency revenue, $254 million of the change is driven by our more efficient Encompass operating model. In Q2, we made a payment of $14 million on our term loan, which reduces our outstanding debt balance to $496 million compared to $667 million of total debt in Q2 of 2022. This results in a reduction of $171 million of debt or 25% over the last 12 months. Consistent with the performance highlighted in our last quarterly earnings call, we continue to see strong momentum in our unit economics. Our unwavering commitment to driving high quality enrollment and leveraging our proprietary tools and technology has yielded remarkable operational efficiencies.
As outlined in our quarterly results presentation, our Q2 2023 adjusted gross margin per submission was $127 marking an impressive 443% increase in profitability as compared to the prior year period. Compared to prior year, we increased our agency commission constraint, which led to a year-over-year decline in sales per submission. However, this is more than offset by the significant efficiencies gained evident in the noteworthy 21% improvement in cost per submission. Our continued growth and strong year-to-date performance enable us to raise the floor and narrow our guidance for the fiscal year, reflecting the competence we have in our trajectory. As Vijay mentioned, we now expect total revenue between $800 million and $850 million an increase from the previous lower bound of $750 million.
Furthermore, our updated projected adjusted EBITDA range is $120 million and $140 million surpassing the previous lower bound of $100 million. Please recall that our guidance excludes non-Encompass BPO services. We are maintaining our current range for cash flow from operations of $75 million to $115 million. As I mentioned in our prior call, our typical seasonality for revenue and adjusted EBITDA peaks during Q4 driven by the annual enrollment period followed by Q1 featuring the open enrollment period, while Q2 and Q3 typically experience more modest revenues and negative adjusted EBITDA due to the lower volumes in the special enrollment period. While we do not guide on a quarterly basis, we do anticipate Q3 to experience sequential declines in revenue and adjusted EBITDA compared to Q2, but expected to outperform Q3 of last year.
We believe our updated guidance illustrates our commitment to drive profitability growth and execute through the more efficient Encompass operating model. The impressive strides we made are a testament to the dedication of our exceptional team and the effectiveness of our strategic initiatives. We’re generating cash and have clear line of sight to achieving our target leverage ratio in Q4 of this year. This is a significant milestone in our journey towards long-term financial strength and stability, setting the stage for continued success and unlocking new opportunities for growth. I’ll now turn it over to Vijay for closing remarks.
Vijay Kotte: Before I move to the question-and-answer session, I want to first make a brief comment on a recent unsolicited [ph] and everything. In May, our Board of Directors confirmed that it had received an unsolicited acquisition proposal. The details can be found in our SEC filings. We also announced that our Board had established a special committee of independent directors to carefully consider the proposal received. As included in our earnings release, the special committee has concluded that the offer undervalue the company and is not in the best interest of GoHealth or its stockholders. We do not have any further updates at this time. We remain appreciative of the continued support and trust from our stockholders. We are focused on delivering value and driving the success of our business while maintaining high standards of corporate governance. With that, we would like to open the call to questions. Operator?
See also 10 Best Warehouse and Self-Storage Stocks To Buy and 10 Best Inexpensive Stocks To Buy Right Now.
Q&A Session
Follow Gohealth Inc. (NASDAQ:GOCO)
Follow Gohealth Inc. (NASDAQ:GOCO)
Operator: Thank you. [Operator Instructions]. Our first question comes from the line of Ben Hendrix with RBC Capital Markets. Your line is open. Please go ahead.
Ben Hendrix: Great. Thank you very much. Congratulations on the quarter. Can you remind us of the mix of Encompass revenue assumed in full-year guidance and then how you’re thinking about that evolving over time? Thank you.
Jason Schulz: Yes. Ben thanks for the question. So we are not going to go ahead and provide the mixed assumption for Encompass for the full-year guidance, but we do believe that it will have a meaningful improvement into our cash flow from operations for the rest of the year. Additionally, I think what’s important; as we talked about in the last quarter, when we have our Encompass model, our operating model materially all of our business is going that — through that operations. And so I think that’s the more important point because that is going to go ahead and continue to drive the more efficient outcomes that we’re talking about on the cost per submission. And so that’s the primary thing I would guide you towards.
Vijay Kotte: Yes, and I’ll add to that, Ben that as just as a disclaimer, right? We said early on this year with all the hard work the team’s done that we wanted to standardize on the Encompass workflow, and that was for our internal captive channel. As you know, you have the external down line agencies, who work with us and collaborate with us, but they’re not on that same platform. So you would see the LION’S share, if not all of the volume running through the Encompass platform and the internal captive agents. And then externally though, we’re starting to test that model. It’s going to be a small portion of that, and so the majority of our external production will be running through the agency line with the LION’s share of the internal volume going through the non-agency line. So hopefully, that’s helpful to you, but I think it’s confident to say that nearly all of the internal volume is going to be running through the Encompass workflow.
Ben Hendrix: Thanks for that color. And then separately, I wondered if you give us an update on how agent retention is trending. It seems like this Plan Fit checkup would be a good way to support agent retention. Just any comments there?
Vijay Kotte: Yes. No, thanks, Ben. On the question, I would say that our team has been super excited about what we’ve been doing with the tools we’re providing for them to make their jobs easier, make it more efficient, a more standardized workflow that comes through Encompass. We have really committed and said out loud, as we said on these calls, that we were going to commit to doing the right thing and even paying our agents for not enrolling a beneficiary, but giving them a high quality selling or shopping experience. And that was really important to us. So we augmented our compensation plans to do just that. If they deliver a high quality shopping experience where they assess the individual’s needs, match them with plans, present those to them, and even if they decide that they’re already in the right plan, they tell them that, they will be compensated for that that time that they spent in the high quality work they did.